Dr. Ajit Singh is Managing Director and General Partner at Artiman Ventures, based in Palo Alto, CA and focuses on early-stage Technology and Life Science investments. On behalf of Artiman, he serves on the Board of Directors of Aditazz, CardioDx, Click Diagnostics, CORE Diagnostics, and OncoStem Diagnostics.
Dr. Singh is also a Consulting Professor in the School of Medicine at Stanford University.
He serves on the Board of Max India Ltd, and is the Lead Director on Board of Directors of Max Healthcare based in New Delhi, India. He also serves on the Board of Directors of Sophie Biosciences – an early stage company focused on molecular imaging, spun out from UCLA and CalTech.
Prior to joining Artiman, Ajit was the President and CEO of BioImagene, a Cancer Diagnostics company that was acquired by Roche in 2010. Before BioImagene, Ajit spent nearly twenty years at Siemens Healthcare in various CEO roles based in the US and Germany. Between 1988 and 1995, he concurrently served on the faculty at Princeton University.
Ajit has a Ph.D. in Computer Science from Columbia University, a Master’s in Computer Engineering from Syracuse University and a bachelor’s degree in Electrical Engineering from Banaras Hindu University, India. He has published two books and numerous refereed articles, and holds six patents.
Ajit is an avid reader, and publishes an annual Top-10 Book Review. He is the Chairman of the Board of Art Forum based in San Francisco, which, along with its parent organization, puts up Asia’s biggest literary gathering, the annual Jaipur Literature Festival.